Martin Shkreli: Big Pharma's Blind Spot, Betting Against Quantum & What Prison Taught Him

Martin Shkreli, a figure synonymous with controversy and sharp intellect, recently sat down to discuss a range of topics, from his skepticism about quantum computing to his experiences in the pharmaceutical industry and the profound impact of his time in prison. Shkreli, who gained notoriety for dramatically increasing the price of a life-saving drug, offers a unique and often provocative perspective on business, technology, and personal growth.

The Quantum Computing "Fraud"

Shkreli minces no words when it comes to quantum computing, labeling it a "fraud" and a "fugazi." His thesis, informed by his wife Chelsea's expertise (a former OpenAI pioneer who studied quantum computing at MIT with Scott Aronson), challenges the popular misconception that quantum computing simply means faster computing. Instead, Shkreli explains that the field's primary breakthrough, Peter Shore's thought experiment, identified a specific type of algorithm that runs faster in a quantum medium—integer factorization or elliptic curve discrete log problems. While this is a "magic trick" to a nerd, he argues it holds little business value unless one is in the niche business of factoring numbers.

He highlights several critical limitations: modern quantum computers operate at clock speeds of hundreds or thousands of hertz, far slower than the gigahertz of traditional computers. They are single-core and single-threaded for common tasks like sorting algorithms, making them inferior to even a single Nvidia machine. Furthermore, quantum computers lack storage, meaning problems must have extremely small inputs. Shkreli notes that major tech companies like Google, IBM, and Microsoft invest in quantum computing with the vague hope that "someday there might be something that comes out of it," a business model he finds unconvincing. He and his wife have personally attempted to multiply 300 by 200 on every quantum computer available globally and failed, underscoring their practical limitations. Despite losing millions shorting quantum computing companies, Shkreli maintains that the insights gained were invaluable.